Prospective Use of Microvolt T-Wave Alternans Testing to Guide Primary Prevention Implantable Cardioverter Defibrillator Therapy.
暂无分享,去创建一个
Antonis A Armoundas | Takanori Ikeda | Daniele Marangoni | Richard J Cohen | Giulio Molon | A. A. Armoundas | Philippe Maury | R. Cohen | T. Ikeda | L. Calò | G. Raczak | L. Daniłowicz-Szymanowicz | M. Piancastelli | P. Maury | Faisal M Merchant | Jorge A Salerno-Uriarte | Faisal M. Merchant | Demet Erciyes | J. Salerno-Uriarte | G. Molon | Grzegorz Raczak | Simona Sarzi Braga | F. Caravati | Fabrizio Caravati | Stefania Falcone | Ludmila Danilowicz-Szymanowicz | Roberto F E Pedretti | Leonardo Calo | Annamaria Martino | Maurizio Piancastelli | A. Martino | S. Sarzi Braga | R. Pedretti | Stefania Falcone | D. Marangoni | D. Erci̇yes | D. Erciyes
[1] L. Stevenson. Projecting heart failure into bankruptcy in 2012? , 2011, American heart journal.
[2] Wenji Pu,et al. Does microvolt T-wave alternans testing predict ventricular tachyarrhythmias in patients with ischemic cardiomyopathy and prophylactic defibrillators? The MASTER (Microvolt T Wave Alternans Testing for Risk Stratification of Post-Myocardial Infarction Patients) trial. , 2008, Journal of the American College of Cardiology.
[3] P. F. Kauff. Group , 2000, Elegant Design.
[4] Antonis A Armoundas,et al. Clinical utility of microvolt T-wave alternans testing in identifying patients at high or low risk of sudden cardiac death. , 2012, Heart rhythm.
[5] T. Ikeda,et al. Simultaneous assessment of T-wave alternans and heart rate turbulence on holter electrocardiograms as predictors for serious cardiac events in patients after myocardial infarction. , 2013, Circulation journal : official journal of the Japanese Circulation Society.
[6] Douglas L Packer,et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. , 2005, The New England journal of medicine.
[7] R. Cohen,et al. Clinical use of microvolt T-wave alternans in patients with depressed left ventricular function eligible for ICD implantation: mortality outcomes after long term follow-up. , 2013, International journal of cardiology.
[8] Harlan M Krumholz,et al. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemaker , 2008, Circulation.
[9] Catherine Klersy,et al. Prognostic value of T-wave alternans in patients with heart failure due to nonischemic cardiomyopathy: results of the ALPHA Study. , 2007, Journal of the American College of Cardiology.
[10] 陈涵. ACC/AHA/HRS 发布新版成人室上性心动过速指南 , 2015 .
[11] Claudia Stöllberger,et al. Guidelines for device-based therapy of cardiac rhythm abnormalities. , 2009, Heart rhythm.
[12] Brahmajee K Nallamothu,et al. Microvolt T-wave alternans identifies patients with ischemic cardiomyopathy who benefit from implantable cardioverter-defibrillator therapy. , 2007, Journal of the American College of Cardiology.
[13] J. Oss,et al. PROPHYLACTIC IMPLANTATION OF A DEFIBRILLATOR IN PATIENTS WITH MYOCARDIAL INFARCTION AND REDUCED EJECTION FRACTION , 2002 .
[14] D. Cohen,et al. The frequency and incremental cost of major complications among medicare beneficiaries receiving implantable cardioverter-defibrillators. , 2006, Journal of the American College of Cardiology.
[15] M. Shoda,et al. Guidelines for Non-Pharmacotherapy of Cardiac Arrhythmias (JCS 2011). , 2012, Circulation journal : official journal of the Japanese Circulation Society.
[16] E. Ghaderi,et al. Advance Publication by J-STAGE , 2017 .
[17] A. Moss,et al. Long-Term Benefit of Primary Prevention With an Implantable Cardioverter-Defibrillator: An Extended 8-Year Follow-Up Study of the Multicenter Automatic Defibrillator Implantation Trial II , 2010, Circulation.
[18] T Sugano,et al. [Heart rhythm]. , 2020, Nihon seirigaku zasshi. Journal of the Physiological Society of Japan.
[19] Richard J Cohen,et al. Interpretation and Classification of Microvolt T Wave Alternans Tests , 2002, Journal of cardiovascular electrophysiology.
[20] Takanori Ikeda,et al. Evidence regarding clinical use of microvolt T-wave alternans. , 2008, Heart rhythm.
[21] J. Ruskin,et al. Electrical alternans and vulnerability to ventricular arrhythmias. , 1994, The New England journal of medicine.
[22] J. Spertus,et al. Impact of Age and Medical Comorbidity on the Effectiveness of Implantable Cardioverter-Defibrillators for Primary Prevention , 2009, Circulation. Cardiovascular quality and outcomes.
[23] M. Josephson,et al. A critical appraisal of implantable cardioverter-defibrillator therapy for the prevention of sudden cardiac death. , 2008, Journal of the American College of Cardiology.
[24] A. A. Armoundas,et al. A combined anatomic and electrophysiologic substrate based approach for sudden cardiac death risk stratification. , 2013, American heart journal.
[25] Wojciech Zareba,et al. Reduction in inappropriate therapy and mortality through ICD programming. , 2012, The New England journal of medicine.
[26] Brahmajee K Nallamothu,et al. Prognostic utility of microvolt T-wave alternans in risk stratification of patients with ischemic cardiomyopathy. , 2006, Journal of the American College of Cardiology.
[27] Kazutaka Aonuma,et al. Epidemiology of arrhythmias and sudden cardiac death in Asia. , 2013, Circulation journal : official journal of the Japanese Circulation Society.